- Home
- CYRX
CYRX
CryoPort Inc.
as 11-01-2025 4:27am EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Upcoming Earnings Alert:
Get ready for potential market movements as CryoPort Inc. CYRX prepares to release earnings report on 04 Nov 2025.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 438.7M | IPO Year: | N/A |
| Target Price: | $12.56 | AVG Volume (30 days): | 762.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.58 - $11.44 | Next Earning Date: | 11-04-2025 |
| Revenue: | $237,879,000 | Revenue Growth: | 24.93% |
| Revenue Growth (this year): | -23.61% | Revenue Growth (next year): | 9.20% |
Stock Insider Trading Activity of CryoPort Inc. (CYRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hariri Robert J | CYRX | Director | Sep 11 '25 | Sell | $9.71 | 25,000 | $242,737.50 | 51,275 | |
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Aug 19 '25 | Sell | $8.67 | 9,300 | $80,617.98 | 207,213 |
Latest CryoPort Inc. News
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
PR Newswire
11 days ago
Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025
Simply Wall St.
13 days ago
A Look at Cryoport's Valuation as New Monitoring Technology Enhances Life Sciences Logistics
Simply Wall St.
14 days ago
Can Cryoport's (CYRX) Smart Monitoring Upgrade Hint at a Shift in Cold Chain Leadership?
Zacks
15 days ago
CryoPort (CYRX) Moves 7.0% Higher: Will This Strength Last?
GlobeNewswire
24 days ago
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
PR Newswire
25 days ago
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
Zacks
4 months ago
CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know
MT Newswires
4 months ago
Cryoport Insider Sold Shares Worth $2,289,781, According to a Recent SEC Filing
Compare CYRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.